Roche Warns On Anti-Trust Zeal While Posting Painful Q1

But Says Biosimilar Erosion ‘Has Already Hit High Watermark’

 
• By Sten Stovall
  
Strong Q1 Diagnostics Offset Limp Drug Sales • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Earnings

More from Business